Linden Advisors’s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock ARCK Stock Holding History

Linden Advisors’s Portfolio ARCK Stock Details ARCK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-197,877	Closed	-$2M	–	620
2022 Q3	$2M	Hold	197,877	–	–	0.02%	342
2022 Q2	$1.99M	Hold	197,877	–	–	0.02%	370
2022 Q1	$1.98M	Buy	+197,877	New	+$1.98M	0.01%	455

Other funds holding ARCK

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Linden Advisors's ARCK Position: Q4 2022 in Review

Linden Advisors sold out of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) in Q4 2022, closing a stake of 197,877 shares — an estimated $2M sold.

Linden Advisors first reported a position in ARCK in Q1 2022 and held it in 3 quarters. The position peaked at $2M in Q3 2022. 2 funds tracked by Wall St. Rank hold ARCK as of Q4 2022.

Linden Advisors reported no remaining Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Linden Advisors sold 197,877 Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock shares in Q4 2022, an estimated $2M.
Linden Advisors first reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in Q1 2022 and held it in 3 quarters.
Linden Advisors's Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position peaked at $2M in Q3 2022.
2 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock as of Q4 2022.

Based on Linden Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.